FDA Approves Game-Changing Non-Opioid Painkiller to Fight Addiction Crisis
31 Jan 2025
The United States Food and Drug Administration (FDA) recently approved a new non-opioid drug, Journavx, developed by Vertex Pharmaceuticals, which represents a groundbreaking shift in pain management. This approval marks a significant milestone in the ongoing effort to combat the opioid crisis that has plagued the country for over two...
Read More